Anti-tumour properties of novel ruthenium complexes containing non-steroidal anti-inflamatory drugs (NSAIDs) (2006)
- Authors:
- USP affiliated authors: COLQUHOUN, ALISON - ICB ; SILVA, DENISE DE OLIVEIRA - IQ
- Unidades: ICB; IQ
- Subjects: RUTÊNIO; QUÍMICA INORGÂNICA
- Language: Inglês
- Imprenta:
- Publisher: European Federation for the Science and Technology of Lipids
- Publisher place: Frankfurt
- Date published: 2006
- Conference titles: Euro Fed Lipid Congress
-
ABNT
COLQUHOUN, Alison et al. Anti-tumour properties of novel ruthenium complexes containing non-steroidal anti-inflamatory drugs (NSAIDs). 2006, Anais.. Frankfurt: European Federation for the Science and Technology of Lipids, 2006. . Acesso em: 27 abr. 2024. -
APA
Colquhoun, A., Benadiba, M., Ribeiro, G., & Silva, D. de O. (2006). Anti-tumour properties of novel ruthenium complexes containing non-steroidal anti-inflamatory drugs (NSAIDs). In . Frankfurt: European Federation for the Science and Technology of Lipids. -
NLM
Colquhoun A, Benadiba M, Ribeiro G, Silva D de O. Anti-tumour properties of novel ruthenium complexes containing non-steroidal anti-inflamatory drugs (NSAIDs). 2006 ;[citado 2024 abr. 27 ] -
Vancouver
Colquhoun A, Benadiba M, Ribeiro G, Silva D de O. Anti-tumour properties of novel ruthenium complexes containing non-steroidal anti-inflamatory drugs (NSAIDs). 2006 ;[citado 2024 abr. 27 ] - The novel ruthenium—γ-linolenic complex [Ru2(aGLA)4Cl] inhibits C6 rat glioma cell proliferation and induces changes in mitochondrial membrane potential, increased reactive oxygen species generation and apoptosis in vitro
- Time-dependent effects of a novel ruthenium complex containing the non-steroidal anti-inflammatory drug (NSAID) ibuprofen on the mRNA expression of proteins involved in cell cycle control, angiogenesis and invasion in C6 rat glioma cells in vitro
- Time-dependent effects of a novel ruthenium complex containing the non-steroidal anti-inflammatory drug (nsaid) ibuprofen on the mRNA expression of proteins involved in cell cycle control, Angiogenesis and Invasion in C6 rat glioma cells in vitro
- Diruthenium(II,III)-non-steroidal anti-inflammatory drug complexes and their effects on tumor-cell proliferation
- Inhibition of C6 rat glioma proliferation by ['RU IND. 2''CL''(ibp) IND. 4'] depends on changes in p21, p27, Bax/Bcl2 ratio and mitochondrial membrane potential
- Diruthenium(II, III) complexes of ibuprofen, aspirin, naproxen and indomethacin non-steroidal anti-inflammatory drugs: synthesis, characterization and their effects on tumor-cell proliferation
- Axially-modified paddlewheel diruthenium(II,III)-ibuprofenato metallodrugs and the influence of the structural modification on U87MG and A172 human glioma cell proliferation, apoptosis, mitosis and migration
- Synthesis and characterization of new diruthenium (II, III) complexes with non-steroidal anti-inflammatory drugs
- Diruthenium (II,III)-ketoprofen anticancer metallodrug investigated for interaction with transferrin and for effects on the antiproliferative activity, apoptotic and mitotic processes in the A172 human glioma cell line
- Growth inhibitory effects of the diruthenium-ibuprofen compound, 'RU IND. 2''CL'(Ibp)' IND. 4', in human glioma cells in vitro and in the rat C6 orthotopic glioma in vivo
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
